AK
Alok Kumar Singh
About Alok Kumar Singh
Data last updated:
Alok Kumar Singh has 16 years in corporate governance. Holds Director and Individual Subscriber roles. Currently with 4 companies, including Dycine Herbal Private Limited and Dycine Neutra Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Dycine Herbal Private Limited U21003UP2025PTC226538 | Director | 20 Jun 2025 | 2025 | Active |
| Dycine Neutra Private Limited U46497UP2026PTC248620 | Individual Subscriber | 02 Jun 2026 | 2026 | Active |
| Dycine Global Pharma Private Limited U46497UP2026PTC249000 | Individual Subscriber | 16 Jun 2026 | 2026 | Active |
 Dycine Pharmaceuticals Limited U74992UP2010PLC041545 | Director | 30 Jul 2010 | 2010 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Pratap Diagnostic Private Limited U85191UP2011PTC046643 | Director | 16 Sep 2011 | 2011 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Alok Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alok Kumar Singh
Alok Kumar Singh has 16 years in corporate governance. Holds Director and Individual Subscriber roles. Currently with 4 companies, including Dycine Herbal Private Limited and Dycine Neutra Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.
Alok Kumar Singh is associated with 4 companies as Director and Individual Subscriber.
Alok Kumar Singh has expertise in General Business.
Alok Kumar Singh has 16 years in corporate governance.